T. Iwahori

Irinotecan hydrochloride (CPT-11) in dialysis patients with gastrointestinal cancer.

T. Yokoyama, Y. Kihara, H. Iwamoto, 2010, Acta medica Okayama.

CYP3A4 inducible model for in vitro analysis of human drug metabolism using a bioartificial liver

T. Matsuura, H. Aizaki, K. Chiba, 2003, Hepatology.

Tolvaptan increases urine and ultrafiltration volume for patients with oliguria undergoing peritoneal dialysis

M. Esaki, T. Iwahori, S. Esaki, 2014, Clinical and Experimental Nephrology.

Reconstruction of liver organoid using a bioreactor.

F. Braet, K. Shimizu, T. Matsuura, 2006, World journal of gastroenterology.

Increased Sensitivities of Peripheral Blood Mononuclear Cells to Immunosuppressive Drugs in Cirrhosis Patients Awaiting Liver Transplantation

K. Oka, T. Nagao, N. Matsuno, 2006, Cell transplantation.

Evidence of different pharmacokinetics including relationship among AUC, peak, and trough levels between cyclosporine and tacrolimus in renal transplant recipients using new pharmacokinetic parameter--why cyclosporine is monitored by C(2) level and tacrolimus by trough level--.

K. Oka, O. Konno, T. Yokoyama, 2008, Biological & pharmaceutical bulletin.

Long‐term follow‐up ABO‐incompatible adult living donor liver transplantation in cirrhotic patients

O. Konno, H. Iwamoto, T. Nagao, 2007, Clinical transplantation.